Login

The article explores how technology is disrupting home insurance, featuring insights from Lemonade Inc. CEO. 00:10:00

Share On Facebook Share On Twitter

John has served as LivePerson's CEO since January 2024.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:00:00
Dr. Bennie Jeng, Cornea expert, Chair of the Department of Ophthalmology
00:10:00
Achieve Your Financial and Lifestyle Goals with Confidence | Michael J. Evans , CFO , Cogent Strategic Wealth.
00:10:00
Central Asia Metals: Sustainable Growth and Robust Dividend Policy
00:10:00
Michael Gokenauer on Janney Montgomery Scott's Five-Year Milestone and Community Engagement
00:10:00
Inflation Unpacked: Expert Analysis by Ryan Craft | Ryan Craft, Senior Investment Analyst, discusses inflation.
00:10:00
JSE-listed Aspen CEO Stephen Saad discusses the challenges of the pharmaceutical industry with CNBC Africa.
00:10:00
focus has given them experience and expertise|Jared Franklin,Vice President,Costanoa Ventures
00:10:00
Evaluating Charities and Tax-Efficient Strategies for Maximizing Your Donations | Michelle Smalenberger, President , Financial Design Studio.
00:10:00
Strategic Vision with Planning Alternatives' President Nathan Mersereau | Nathan Mersereau, President, Planning Alternatives Ltd.
00:10:00
Enriching Communities: Malakoff's Sustainability Journey and CSR Initiatives | Anwar Syahrin Bin Abdul Ajib, CEO, Malakoff Corp Bhd.
00:10:00
Private Markets Outlook: Global Trends, India's Potential, and Investment Strategy | Rishi Kapoor, CO-CEO, Investcorp Inc.
00:10:00
The Foundation of Successful Investing: Insights from Allodium Investment Consultants | David J. Bromelkamp - CEO of Allodium Investment Consultants

© 2026 Nehu